BDNF and treatment resistant depression: Collectively, these findings suggest that coordinated NMDA inhibition and AMPA potentiation regulate synaptic plasticity, BDNF release, and glutamate signaling that underpin both TRD vulnerability and the mechanism of ketamine and esketamine response.